Skip to content

Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury

Optimization of Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06489106
Enrollment
10
Registered
2024-07-05
Start date
2025-06-13
Completion date
2027-07-31
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury Cervical

Keywords

Pediatric onset, Transcutaneous spinal cord stimulation, Hand and arm function, Chronic spinal cord injury

Brief summary

The main goal of this pilot study is to find the best ways to use transcutaneous spinal cord stimulation (scTS) to improve hand function in children with spinal cord injuries (SCI). The investigators will start by exploring the best places and strengths for applying scTS on the neck, the added benefits of applying scTS on the lower back (T11-T12), and comparing the effects of using activity based upper extremity training (a control treatment) alone versus combining it with scTS to help children with chronic SCI regain hand function.

Detailed description

After learning about the study and potential risks, parents/legal guardians and their eligible children with SCI will sign consent and assent forms, respectively. For the first two aims of the study, the investigators will recruit and enroll 10 participants. In the first week, participants will undergo clinical assessments from day 1 to day 4 to categorize the severity and level of their injuries and assess their current arm and hand function. On day 5, eligible participants will have experimental assessments to measure hand grip and control, both with and without spinal cord stimulation (scTS) at one or two neck sites optimized to improve hand grip. On day 6, participants will have similar assessments, this time adding stimulation to the trunk area to help with upright sitting and study its impact on hand grip and control. For the third aim, 4 participants who showed improved hand grip and control with stimulation in aims 1 and 2 will be selected on a first-come, first-served basis. They will undergo 20 sessions of activity-based upper extremity training, followed by 20 more sessions with the optimal stimulation sites identified from aims 1 and 2. After completing the training, participants will be asked to follow up and repeat experimental and clinical assessments to determine how long the improvements last.

Interventions

DEVICEActivity based upper extremity training with and without stimulation

Activity-based upper extremity training (AB-UET) will be administered 5d/week and 1 hour 30 minutes/session. For AB-UET+ stimulation (scTS), UE tasks will be repeated with and without scTS so that scTS is administered intermittently for the duration of \~ 10 minute/bouts.

Sponsors

University of Louisville
Lead SponsorOTHER
The Craig H. Neilsen Foundation
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

For aim 1 and 2, 10 participants with SCI: 1. age 7-12 years; 2. chronic (\>6 months), acquired upper motor neuron SCI; 3. cervical SCI at or above C8 neurological level with motor score of 1-3 for finger flexors 4. Pediatric Neurorecovery scale score of ≥2B and ≤ 4C for impaired grip For Aim 3, 4 participants with SCI who: 1. complete aim 1 and 2; 2. consent/assent for aim 3 3. demonstrate a minimum of 10% increase in HG force with scTS (aim1-2) 4. confirmed volitional activation in hand muscles during hang grip assessment without scTS

Exclusion criteria

For all 3 aims will include: 1. Botox use within past 3 months (for upper or lower extremity); 2. current oral baclofen (or pump); 3. musculoskeletal impairment limiting range of motion; 4. unhealed fracture or other medical condition limiting participation in AB-UET; 5. etiology of spina bifida; 6. total ventilator dependence.

Design outcomes

Primary

MeasureTime frameDescription
Hand grip12 weeksVoluntary maximal hand grip force
Hand control12 weeksPeak to peak distance on hand grip force

Secondary

MeasureTime frameDescription
Functional neurophysiological assessment-Upper extremity12 weeksMulti-muscle activation patterns
Pediatric Neurorecovery scale12 weeksPediatric Neurorecovery scale (NRS) is a validated clinical scale that assesses a child's (age 1-12 years) neuromuscular capacity to perform everyday tasks without behavioral compensation, physical assistance, or assistive device. The total score is the sum of all tasks on a scale from 1-12. For a total of 12 items, the highest score being 144 and lowest a sore of 12. Higher scores indicate improved function.
Capabilities of upper extremity test12 weeksThe Capabilities of the Upper Extremity Test (CUE-T) is a performance measure intended to assess upper extremity function following spinal cord injury. The CUE-T is an objective measure of the ability to complete actions and tasks involving the arm and hand in individuals with tetraplegia and can be used clinically, for research and in clinical trials. Respondents answer questions on a 7-point scale that represents their self-perceived difficulty in performing the action, with 1 indicating "totally limited, can't do at all" and 7 indicating "not at all limited". The total score is the sum of all responses, and ranges from 32 to 224, with higher scores indicating greater function.
Box and block test12 weeksThe Box and Block Test (BBT) measures unilateral gross manual dexterity and is validated in pediatric population. The score is the number of blocks carried from one compartment to the other in one minute. Each hand is scored separately. Higher scores within 1-minute indicate better manual dexterity.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORGoutam Singh, PhD

University of Louisville and Spalding University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026